ArriVent BioPharma EPS AVBP

Diluted earnings per share by quarter and over the last twelve months, from 2023.

ArriVent BioPharma's earnings per share was −$3.67 over the twelve months to Jun 30, 2026.

In its latest quarter, Q2 FY26, it was −$1.05.

Earnings per share over time

Each fiscal year is the twelve months to its fourth quarter.

Quarter	Ended	EPS	On a year earlier	Last 12 months
Q2 FY26	Jun 30, 2026	−$1.05	n/a	−$3.67
Q1 FY26	Mar 31, 2026	−$0.96	n/a	−$3.52
Q4 FY25	Dec 31, 2025	−$0.83	n/a	−$4.46
Q3 FY25	Sep 30, 2025	−$0.83	n/a	−$4.24
Q2 FY25	Jun 30, 2025	−$0.90	n/a	−$4.02
Q1 FY25	Mar 31, 2025	−$1.90	n/a	−$3.77
Q4 FY24	Dec 31, 2024	−$0.61	n/a	−$2.57
Q3 FY24	Sep 30, 2024	−$0.61	n/a	−$9.78
Q2 FY24	Jun 30, 2024	−$0.65	n/a	−$14.69
Q1 FY24	Mar 31, 2024	−$0.70	n/a	−$24.83
Q4 FY23	Dec 31, 2023	−$7.82	n/a	−$33.58
Q3 FY23	Sep 30, 2023	−$5.52	n/a	n/a

Companies in Drug Manufacturers - General nearest ArriVent BioPharma's size, closest first, today.

Company	EPS, 12 months	Growth
AVBPArriVent BioPharma	−$3.67
AMPHAmphastar Pharmaceuticals	$1.70	−36% a year
OMEROmeros	$1.52
ABUSArbutus Biopharma	$0.78
COLLCollegium Pharmaceutical	$1.24	+19% a year
PCRXPacira BioSciences	$0.35
ANABAnaptysbio	$4.57
PAHCPhibro Animal Health	$2.44	+107% a year
ANIPANI Pharmaceuticals	$4.70
CRMDCorMedix	$2.13	+184% a year
ZVRAZevra Therapeutics	$0.93
Peer median	$1.61